Movetis Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 29
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $528M
Latest Deal Amount

Movetis General Information

Description

Developer of drugs for the treatment of diseases in the gastrointestinal (GI) area. The company's products address GI disorders, such as severe chronic constipation, ascites, paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. Its lead product, Resolor, is used for the symptomatic treatment of chronic constipation in women.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Veedijk 58 1004
  • 2300 Turnhout
  • Belgium
+32 014 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Movetis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Nov-2010 $528M 00000 00000 Completed Generating Revenue
2. IPO 03-Dec-2009 00000 00000 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 08-Jan-2007 $64.4M $64.4M Completed Product Development
To view Movetis’s complete valuation and funding history, request access »

Movetis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Movetis Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BIP Investment Partners PE/Buyout Minority 000 0000 000000 0
Gimv PE/Buyout Minority 000 0000 000000 0
KBC Group Corporation Minority 000 0000 000000 0
Life Sciences Partners Venture Capital Minority 000 0000 000000 0
Quest For Growth Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »